Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?

Patients with antiphospholipid syndrome (APS) are at increased risk of recurrent thromboembolic events due to the pathology of the disease. While prolonged anticoagulation is the treatment of choice for patients with thrombosis, much debate remains about the optimum intensity of anticoagulation. Ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Esther, Do, Tiffanie, Peacock, Katie, Takundwa, Prisca T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045335/
https://www.ncbi.nlm.nih.gov/pubmed/27725921
http://dx.doi.org/10.7759/cureus.765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045335/
https://www.ncbi.nlm.nih.gov/pubmed/27725921
http://dx.doi.org/10.7759/cureus.765

Ejemplares similares